Dade Behring consolidation means growth in 1998
This article was originally published in Clinica
Executive Summary
Dade Behring expects to achieve growth in both sales and operating income in 1998 as the full results of Behring - acquired last October - are included and as cost-cutting savings are implemented. The merger between the two diagnostics companies - Dade International and Behring Diagnostics - created the world's largest independent clinical chemistry company (see Clinica No 748, p 1).